Literature DB >> 6123741

Pseudomonas aeruginosa isolates with modified beta-lactamase inducibility: effects on beta-lactam sensitivity.

D M Livermore, R J Williams, M A Lindridge, R C Slack, J D Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6123741     DOI： 10.1016/s0140-6736(82)92474-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosa.

Authors:  M L Gates; C C Sanders; R V Goering; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

2.  Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.

Authors:  T Y Langaee; L Gagnon; A Huletsky
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates.

Authors:  D M Livermore; C S Jones
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 4.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 5.  Quo vadis with bacterial resistance?

Authors:  J D Williams
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 6.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Detection of PSE-2 beta-lactamase in enterobacteria.

Authors:  D M Livermore; J P Maskell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 8.  Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.

Authors:  R P Mouton
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

9.  Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa.

Authors:  C C Sanders; M L Gates; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.

Authors:  M Berrazeg; K Jeannot; Véronique Yvette Ntsogo Enguéné; I Broutin; S Loeffert; D Fournier; P Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.